⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

SRPT

Sarepta Therapeutics, Inc.

Healthcare · Biotechnology

17.73USD

-0.4500 (-2.48%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SRPT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 17.73
P/E—
Dvd Ind Yld0.0%
P/B1.23
P/S1.3
Curr EV/T12M EBITDA-122.4
Mkt Cap (USD)1.9B
Curr EV (USD)2.1B
2)

Per Share Data

EPS T12M-1.60
DPS—
Bk Val Per Sh14.47
Rev/Sh13.96
Cash/Sh7.47
Curr Shares Out105.6M
FCF/Sh0.78
3)

Cash Flow Analysis

P/CF16.9
Curr P/FCF22.9
CF/NI-0.8
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales7.5%
Eff Interest Rate-8.2%
4)

Growth Potential

Dil EPS 1Y Gr-404.7%
Cap 1Y Gr-26.1%
BPS 1Y Gr-19.6%
R&D To Sales49.1%
Retention Rate100.0%
Rev 1Y Gr4.3%
FCF 1Y Gr10.3%
Assets 1Y Gr-15.5%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-9.7%
Pretax Margin-8.9%
Net Margin-9.3%
ROA-4.0%
ROE-9.3%
ROC—
Asset Turnover0.43
6)

Structure

Current Ratio4.42
Quick Ratio2.44
Debt/Assets26.6%
Debt/Com Eq55.5%
Net Debt/EBITDA-2.81
Tot Debt/Capital35.7%
Gross Margin69.6%
EBIT/Int Exp1.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.